Drug lookup
Drug reference

Secnidazole

Second-generation nitroimidazole antimicrobial · Antiprotozoal, Anti-infective

Also known as Secnil, Seczol, Secro, Solosec

START
Single 2 g oral dose (granules on soft food); treat partner for trichomoniasis
TYPICAL MAX
2 g single dose
STOP IF
Hypersensitivity reaction; neurologic symptoms (rare)
WATCH
Counsel alcohol avoidance (class caution), breastfeeding interruption ~96 h, candidiasis after BV treatment
CDSCO approvedATC P01AB07
Renal dose adjustmenteGFR mL/min/1.73m²
FULLUsual single dose30CAUTIONLimited data — use with caution90

KDIGO 2024 + manufacturer label

Pharmacokineticsplasma · t hours
4hONSET4hPEAK22h1dDURATION
ONSET
4h · absorption
PEAK
4h · Cmax
22h · plasma t½
DURATION
1d · single-dose (prolonged effect)
EXCRETION
Hepatic metabolism; ~15% renal unchanged
route + CYP
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
Avoid first trimester; later only if clearly needed (limited data; nitroimidazole class)
FDA category + note
Top interactionssee all 4
  • WarfarinSevereDatabaseKimi deep-research + Cla
Available in India

22 branded formulations. Look up specific brands in the Drugs workspace.

Mechanism

Nitro group reduced intracellularly in anaerobes/protozoa to reactive species causing DNA strand breakage and cell death; long half-life enables single-dose therapy.

Indications

Bacterial vaginosis (single-dose, oral granules)TrichomoniasisAmoebiasis and giardiasis (region-dependent)

Dosing

Adult
Bacterial vaginosis/trichomoniasis: single 2 g oral dose (granules sprinkled on food). Amoebiasis/giardiasis: 2 g single dose (or per regional regimen).
Pediatric
30 mg/kg single dose (max 2 g) where indicated (region-dependent).
Renal adjustment
No specific adjustment (single dose; caution ESRD).
Hepatic adjustment
Caution in significant hepatic impairment (reduced clearance).
Geriatric
No specific adjustment.
Max dose
2 g single dose

Pharmacokinetics

Onset
Antimicrobial over the days following single dose
Peak effect
Cmax ~4 h
Duration
Prolonged (single-dose efficacy)
Half-life
~17–29 h (long — basis for single dosing)
Bioavailability
Well absorbed orally
Protein binding
<15%
Metabolism
Hepatic
Excretion
Renal (≈15% unchanged) and metabolites

Contraindications

  • Hypersensitivity to nitroimidazoles
  • Caution: blood dyscrasias, CNS disease; alcohol (disulfiram-like — class caution)

Side effects

Common
Nausea/dysgeusia (metallic taste)HeadacheVulvovaginal candidiasis (BV treatment)Abdominal discomfort/diarrhoeaVomiting
Serious
  • Hypersensitivity reactions
  • CNS effects (rare — peripheral neuropathy/seizures, class, with prolonged/high exposure)
  • Possible disulfiram-like reaction with alcohol (nitroimidazole class)

Pregnancy & lactation

Pregnancy

Avoid first trimester; later only if clearly needed (limited data; nitroimidazole class)

Lactation

Avoid breastfeeding during and for ~96 h (long half-life) after the single dose

Drug interactions

Warfarin
Severe
Database

Nitroimidazoles potentiate warfarin → raised INR/bleeding

Monitor INR; adjust warfarin

Source: Kimi deep-research + Cla

Disulfiram
Moderate
Database

Acute psychosis/confusion reported with nitroimidazoles

Avoid combination

Source: Kimi deep-research + Cla

Alcohol
Moderate
Database

Possible disulfiram-like reaction (nitroimidazole class)

Avoid alcohol during and for ~3 days after

Source: Kimi deep-research + Cla

Lithium
Moderate
Database

Possible raised lithium levels (class)

Monitor lithium

Source: Kimi deep-research + Cla

8 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Ask House about Secnidazole

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Harrison 22e·Verified: 2026-05-19 · House clinical team·Cockpit curated: 2026-05-19